Home MarketJubilant Life Sciences Ltd.

Jubilant Life Sciences Ltd. Stock Info: As on 2017-12-15 15:59:43



52 Week Range
Day's Range534.24 - 801.36
Value Traded (in ₹ Cr.) 20.14



Change %
52 Week Range
Day's Range534.44 - 801.66
Value Traded (in ₹ Cr.) 1.71

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 6,970,380.00 4.38%
IndianPromoters 79,080,676.00 49.65%
Mutual Funds/UTI 7,598,928.00 4.77%
FII 30,863,510.00 19.38%
Employee 0.00 0.00%
Public 21,987,068.00 13.80%
Government 0.00 0.00%
Others 8,420,281.00 5.29%

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 2.50
Basic EPS (Rs.) 4.96
Cash EPS 10.42
BVPerShare Excl 124.45
Operating Revenue 166.74
PBDITPerShare 25.27
Dividend 3.00
NPPerShare 4.96
Current Ratio 0.89
Quick Ratio 0.49
PriceToBV 3.35
Earnings 0.01
PBDIT Margin 15.15
PBT Margin 3.44
NP Margin 2.97
Return On Assets 1.75
Retention Ratios 39.56
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 2,717.91
Total Expenses 2,604.57
EBITDA 402.63
PBT 91.41
PAT 79.07
Net Income 79.07
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 1,289.82
Total Expenses 1,152.62
EBITDA 93.58
PBT 30.19
PAT 20.76
Net Income 0.00
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 15.93
Net worth 1,982.50
Investments 1,706.83
Total Liability 4,503.45
Total debt 1,556.53
Net block 1,446.95
Total Assets 4,503.45
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 15.93
Net worth 1,982.50
Investments 1,706.83
Total Liability 4,503.45
Total debt 1,556.53
Net block 1,446.95
Total Assets 4,503.45
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

550.3 540.15 1.88

Abbott India Ltd.

5436.85 5438.6 -0.03

Ajanta Pharma Ltd.

1433.25 1446.7 -0.93

Albert David Ltd.

337.8 336.2 0.48

Alembic Ltd.

42.9 41.9 2.39

Alembic Pharmaceuticals Ltd.

528.2 525.2 0.57

Alkem Laboratories Ltd.

2106.4 2089.85 0.79
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

68.6 60.9 12.64

Aarti Drugs Ltd.

554 545.5 1.56

Aayush Food & Herbs Ltd.

71.25 74.35 -4.17

Abbott India Ltd.

5400 5453.55 -0.98

ABL Bio-Technologies Ltd.

0.81 0.78 3.85

Addlife Pharma Ltd.

0.46 0 0

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities 140.37
Cash from investing activities 521.70
Cash from financing activities -760.51
Net change in cash -98.44

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
Motilal Oswal MOSt Focused Multicap 35 Fund 3.38%
Motilal Oswal MOSt Focused Dynamic Equity Fund 2.78%
Motilal Oswal Most Focused Long Term Fund 4.10%
LIC MF Mid Cap Fund 1.64%
LIC MF Tax Plan 1.69%
Motilal Oswal MOSt Shares Midcap 100 ETF 0.63%

Quess Corp completes 51% acquisition in Trimax Smart

Bangalore-based Quess Corp on Friday said it has acquired 51 per cent stake in Trimax Smart Infraprojects Private Limited. “The company has completed acquisition of 51 per cent equity in Trimax Smart Infraprojects Private Limited, on December 15, 2017,” Quess Corp said in a filing to the Bombay Stock Exchange. Meanwhile, shares of company closed day’s trade at Rs 1035.95 apiece, up 1.50 per cent, on the BSE today.

15-12-2017 18:27

Wipro’s Topcoder launches crowdsourcing community

Wipro's Topcoder has launched the Topcoder Veterans Community to provide employment opportunities for current and former members of the United States military. Topcoder became a part of Wipro in November 2016. The community will help US military veterans develop technology skills and earn money by working on projects for Topcoder customers, including the US Department of Veterans Affairs (VA) and some of the world’s largest enterprises. “The launch of the Topcoder Veterans Community represents a major milestone in our ongoing mission to help Veterans develop new skills and successfully transition to meaningful civilian jobs,” said Jarah Meador, Innovation Sourcing Lead, US Department of Veterans Affairs Center for Innovation. “This community helps the VA, as well as other organizations, accelerate technology innovation development while supporting important workforce development for Veterans” The Topcoder Veterans Community is built with Hybrid Crowd, an extension of the Topcoder platform that enables customers to crowdsource work from private and certified networks of talent in addition to Topcoder’s public community of more than 1 million members around the world. Private and certified networks can be comprised of an enterprise’s employees, vendors, and contractors, as well as specialized groups such as armed forces veterans. “The Topcoder Veterans Community showcases how both employees and organizations are adopting new models of work,” said Mike Morris, CEO, Topcoder. “We’re excited about the opportunities this community creates for veterans to hone their technology skills and for customers to tap into this deep pool of talent.” The VA is launching numerous technology development projects on Topcoder that will be crowdsourced from members of the Topcoder Veterans Community. One such project running now is the VA PseudoVet Challenge where participants have to build a system that creates and updates simulated patient data. Topcoder has committed $100,000 in prizes for winners across all VA projects. Other Topcoder customers can also crowdsource work from the Topcoder Veterans Community, and veterans can compete in other crowdsourcing competitions available to Topcoder’s global public community.

15-12-2017 17:46

Bhel bags Rs 7,300 cr order to set up plant in Tamil Nadu

Power equipment maker Bhel said today that it has won a Rs 7,300 crore order for setting up a Supercritical Thermal Power Project (TPP) in Tamil Nadu. The order for setting up the 2x660 MW Udangudi TPP has been placed on the state-owned firm by Tamil Nadu Generation and Distribution Corporation Ltd (TANGEDCO), Bhel said in a statement. This is the fourth order for supercritical sets finalised in the last three years by TANGEDCO, and all the four orders have been won by Bhel. The previous three orders viz 2x660 MW Ennore SEZ, 1x800 MW North Chennai Supercritical TPP Stage-III and 2x800 MW Uppur TPP were also secured by Bhel on International Competition Bidding (ICB) basis, the company said. Located at Udangudi in Thoothukudi district of Tamil Nadu, the greenfield project will be executed by Bhel on Engineering, Procurement, Construction (EPC) basis. The Bhel's scope of work in the current contract involves design, engineering, manufacture, supply, erection, commissioning and civil works for the entire plant including sea water intake & outfall systems. The key equipment for the project will be manufactured at Bhels various plants across the country including Trichy, Haridwar, Bhopal, Thirumayam and Bengaluru. Its 'Power Sector - Southern Region' will be responsible for civil works, erection and commissioning of the equipment. The implementation of the new projects will help foster growth in Tamil Nadu and provide easy access to electricity to the people of the state. Bhel has a significant share of 83 per cent in the states coal-based generating capacity and has been a major partner in the power development programme of Tamil Nadu

15-12-2017 16:22

Torrent Pharma raises Rs 1,000 cr via NCDs

Torrent Pharmaceuticals said it has raised Rs 1,000 crore through issuance of non- convertible debentures (NCDs) on private placement basis, reported PTI. It however did not disclose what it proposes to do with the money raised. The company has issued non-convertible debentures for an amount of Rs 1,000 crore on December 14, 2017, Torrent Pharmaceuticals said in a filing to BSE. The tenure of allotment is eight years and the date of maturity is December 12, 2025, it added. The NCDs have been listed on the wholesale debt market segment of the National Stock Exchange, it said.

15-12-2017 15:56

Yes Bank to join S&P BSE Sensex from Dec 18

Yes Bank will join the list of 30 most tracked stocks in the bellwether index S&P BSE Sensex from next week. Yes Bank will be included in the S&P BSE Sensexcomprising of 30 companies with effect from December 18, 2017, Yes Bank said in a regulatory filing. The S&P BSE Sensex measures performance of the 30 largest, most liquid and financially sound companies across key sectors that are listed on BSE. Meanwhile, shares of the Bank closed trading at Rs 316.05 apiece, up 3.98 per cent from the previous close on BSE.

15-12-2017 15:46

Ind-Ra affirms Jubilant Consumer at ‘IND BBB-’

India Ratings and Research (Ind-Ra), a part of Fitch group, has affirmed Jubilant Consumer Private Limited’s (JCPL) Long-Term Issuer Rating at ‘IND BBB-’, with stable outlook. The ratings reflect the potential financial support from the Jubilant Bhartia Group (JBG) and JCPL’s readily monetisable assets (RMAs) in the form of a 44.94 per cent stake worth INR53.1 billion in Jubilant FoodWorks Limited (JFW), said Ind-Ra. The agency said that JCPL’s operational scale remains small, despite inheriting the businesses of erstwhile Jubilant Fresh Pvt Ltd and adding a few other segments in FY16 and FY17. The majority (54%) of the revenue is generated from the sale of cut vegetables to JFW. Besides, JCPL’s profitability has been affected, as it has entered into new business segments (Go Gourmet, canned food and ready to eat, customised food solutions) during FY17 and FY18. Fixed costs incurred on new ventures and low EBITDA margin in the existing segments pressure EBITDA for JCPL. Ind-Ra expects EBITDA margins of new ventures to gradually improve, as additional fixed expenses would reduce.

05-Dec-2017 12:59 PM

Jubilant Life Scienc - News Verification

The Exchange has sought clarification from Jubilant Life Sciences Limited with respect to recent news item captioned Jubilant''s Rs.250cr project gets nod. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jubilant Life Sciences Limited has submitted their response.

04-Dec-2017 03:25 PM

Jubilant Life Scienc - Clarifies on news item

With reference to news appeared in www.business-standard.com dated December 03, 2017 quoting Green panel nod to Jubilant Life's Rs 250-cr pesticide project in Gujarat, Jubilant Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed.

04-Dec-2017 03:23 PM

Jubilant Life Scienc - News Verification

The Exchange has sought clarification from Jubilant Life Sciences Limited with respect to recent news item captioned Jubilant''s Rs.250cr project gets nod. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

04-Dec-2017 11:40 AM

Jubilant Life Scienc - Clarification sought from Jubilant Life Sciences Ltd

The Exchange has sought clarification from Jubilant Life Sciences Ltd on December 04, 2017 with reference to news appeared in www.business-standard.com dated December 03, 2017 quoting Green panel nod to Jubilant Life's Rs 250-cr pesticide project in Gujarat.

The reply is awaited.

04-Dec-2017 11:24 AM

Jubilant Life Scienc - Clarifies on news item

With reference to news appeared in www.business-standard.com dated December 03, 2017 quoting Green panel nod to Jubilant Life's Rs 250-cr pesticide project in Gujarat, Jubilant Life Sciences Ltd has submitted to BSE a copy of Clarification is enclosed.

04-Dec-2017 03:23 PM

Jubilant Life Scienc - Clarification sought from Jubilant Life Sciences Ltd

The Exchange has sought clarification from Jubilant Life Sciences Ltd on December 04, 2017 with reference to news appeared in www.business-standard.com dated December 03, 2017 quoting Green panel nod to Jubilant Life's Rs 250-cr pesticide project in Gujarat.

The reply is awaited.

04-Dec-2017 11:24 AM

Jubilant Life Scienc - Updates

Pursuant to the provisions of Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that Drug Discovery and Development Solutions Limited, Singapore ('DDDSL'), a wholly-owned subsidiary company, has entered into Stock Purchase Agreement for acquiring entire Equity Share capital of Jubilant Discovery Services Inc., USA ('JDSI') on November 21, 2017, subject to applicable laws.

JDSI is a step-down subsidiary whose share capital is held by Jubilant Biosys Limited, a step-down subsidiary of the Company.

After the said acquisition of shares, JDSI shall become a wholly-owned subsidiary of DDDSL.

22-Nov-2017 05:37 PM

Corporate Details

About Management

YEAR EVENTS 1978 - The Company was incorporated on 21st June, in Uttar Pradesh. The Company manufacture Vinyl Acetate Monomer (VAM). The Company was promoted by A.B. Bofors (Swedish Multinational), Hindustan Wires Ltd., and Mr. M.L. Bhartia. - The Company entered into a technical collaboration agreement with Noble Chematur Division of A.B. Bofors, Sweden for the supply of know-how and basic engineering for the manufacture of vinyl acetate monomer. 1981 - 1,200 No. of equity shares subscribed for by the signatories to the Memorandum of Association. 34,63,800 No. of equity and 38,500 Pref. shares issued through a prospectus during Mar./Apr. 1982, 19,250 Pref. shares each reserved and allotted to UPSIDC and PICUP. 6,08,370 No. of equity shares reserved and allotted to Indian private promoters and their associates, 6,55,430 No. of equity shares reserved and allotted to AB Brothers of Sweden and 22,00,000 No. of equity shares offered at par for public subscription. Pref. shares redeemable during 28.5.1993/96. 1982 - 6,93,000 Rights Equity shares issued at par in prop. 1:5 (only 5,52,043 shares taken up). The remaining 1,40,357 shares allotted on private placement basis (including 96,800 shares to non-residents). 1983 - Another technical collaboration agreement was signed with Crown Decorative Products Ltd., U.K., and Reed International Company for the manufacture of high pressure emulsions i.e., Polyvinyl Acetate Emulsions. This project was commissioned in 1985-86. - During November, the Company promoted `India Glycols Ltd.' to take up the implementation of a project to manufacture Mono Ethylene Glyco (MEG) at Kashipur, U.P., in technical collaboration with Scientific Design Co. Int., U.S.A. Commercial production commenced on 1st January, 1990. 1984 - A technical collaboration agreement was signed with Technimont Spa of Italy for the manufacture of polyvinyl alcohol with an installed capacity of 2,000 tonnes per annum. The unit was commissioned in July 1991, with an installed capacity of 650 MT per annum. During 1991, the capacity was doubled to 1,400 tonnes per annum. The Company proposed to enhance the capacity of 2,000 MT per annum by installing additional equipment. 1985 - Vam Leasing Ltd., and Vam Investments Ltd., were incorporated as wholly owned subsidiaries of the Company. 1986 - 10,06,180 No. of equity shares issued at par to financial institutions on conversion of loans. 1987 - The Company decided to set up a plant to recover carbon dioxide in collaboration with Hydrogas Denmart a.s. of Denmark and manufacture to dry ice. The plant was commissioned in 1989. A biogas plant was also set up in collaboration with Biotim N.V. of Belgium as a part of energy conservation programme. - The Company also promoted `Insilco Ltd.' jointly with Degussa AG of West Germany for the manufacture of spray dried silica. The project was expected to go on stream by the middle of 1991. - Applications were also submitted to Government for increasing the production capacity of vinyl acetate monomer from 10,000 tonnes to 20,000 tonnes per annum. - In order to part finance the vinyl acetate monomer project, during January, the company privately placed with financial institutions, 15% non-convertible debentures worth Rs 1.00 crores. These debentures are redeemable at a premium of 5% in three equal annual instalments commencing on 27th April, 1993. - The Company privately placed with financial institutions 14% non-convertible debentures worth Rs 1.50 crores. These debentures are redeemable in full at a premium of 5% on 29th December, 1994. 1989 - A synthetic wood adhesive "Vamicol" was launched in January and liquid and dry carbon-di-oxide (dryice) were launched in March. The company installed another new boiler of capacity 25 tonnes steam/hour based on the fluidised bed technology to eliminate air pollution. - The Company privately placed with financial institutions 14% non-convertible debentures worth Rs 10 crores. These debentures are redeemable in full at a premium of 5% on 25th June, 1996. 1990 - The Company commissioned a plant with an installed capacity of 500 tonnes per annum for the manufacture of pyridine and picoline. - The Company undertook to expand the production capacities of vinyl acetate monomer and its intermediaries i.e., acetic anhydride and acetic acid. The expanded capacities were commissioned in October 1990. - The Company privately placed 14% redeemable non-convertible debentures of Rs 100 each aggregating Rs 5.00 crores. These debentures are redeemable at a premium of 5% in three equal annual instalments commencing on 11th September, 1996. - During the year, another 5,00,000-14% redeemable non-convertible debentures of Rs 100 each were privately placed with a provision to redeem at a premium of 5% in three equal instalments commencing on 29th March, 1997. 1992 - Ramganga Fertilizers Ltd. (RFL) was amalgamated with the company effective 1st April, as per BIFR Scheme. As per the scheme of amalgamation 2,56,522 No. of equity shares of Rs 10 each were issued at par to the shareholders of erstwhile RFL in the ratio of one equity share of the company for every 10.35 No. of equity share of Rs 10 each fully paid-up of the erstwhile RFL. 1995 - A technical collaboration agreement was signed with Kemira Coatings Ltd., U.K., to manufacture wood finishes a polymer based product. Another agreement was also signed with M/s. Teutoburg, Germany to manufacture construction chemicals in its plant at Gajraula. - The company proposed to install an additional turbine generator with a capacity of 5.5 MW in view of high and frequently incidence of power failure and fluctuation. The company also proposed to increase the installed capacity of Pyridine & Picolines by 4,000 tonnes per annum to meet the increasing demand for the products. - 2,56,522 No. of equity shares issued to the shareholders of erstwhile RFL on merger of the said company with company. 1996 - The Company proposed to open offices in Singapore to cater to the need of S.E. Asia & China & European markets. With a view to tackling the power failure and fluctuations, the company proposed to instal a turbine generator with a capacity of 5.5 MW. - The company made a capital expenditure of Rs 26.40 crores for taking up projects such as Pyridene & Picolines, wood furnisher, construction chemicals with the intention of saving valuable foreign Exchange. It was also proposed to modernise its sulphuric acid plant. With a view to saving energy the company proposed to instal biogas fired boiler. 1997 - The Company faced a sharp decline in sales realisation of Acetic Acid and VAM, due to a combination of the South East Asian financial debacle and the large capacity build up of Acetic Acid and VAM in South Korean and Singapore. - The company has embarked on a substantial capital expenditure programme to enhance capacities of existing products and also manufacture new products. - Vam Organic Chemicals Ltd has registered a 8.97 per cent increase in net profit for the year ended March 31, 1997 at Rs.23.07 crores as compared to Rs.21.17 crores in the previous year. 1998 - Vam Organics Chemicals has introduced a specialist adhesive Vam Bond 2001. - The dry silica venture, jointly promoted by Vam Organics and Degussa AG of Germany with a 34 per cent stake each has not been doing too well. - The company's performance has been affected due to low international prices, steady increase in prices of major raw materials and sluggish growth in the overall market. - VAM Organic Chemicals Ltd (VOCL) proposes to merge group companies Anichem India Ltd (AIL) and Enpro Speciality Chemicals Ltd (ESCL) with itself. - A planned shut-down of the fertiliser plant was undertaken for 72 days in the quarter for revamping. It also increased its installed capacity from 125 tonnes per day to 175 tonnes per day for sulphuric acid. A captive power plant of 12.45 MW was commissioned in July this year. - VAM Organic Chemicals Ltd is exploring the possibility of entering into areas such as sugar, speciality chemicals and bulk drugs. - The non-convertible debenture programme of Vam Organic Chemicals Ltd has been downgraded by ICRA to LA- LAA-. Vam was the largest player in the alcohol-based organic chemical industry with the largest capacities in the country for most of its products including acetic acid, acetic anhydride, etc. 1999 - VAM Organic Chemicals Ltd (VOCL) has proposed to consolidate and improve its existing position in the chemical industry in the current fiscal. - VOCL has also commissioned the units of Polychem Ltd, manufacturing alcohol-based chemicals in May. - The Company's 22,500 tonnes per annum formaldehyde plant has been commissioned, permitting it to export greater quantities of picolines and pyridines. It has also installed new boilers and increased the capacities of existing plants. 2000 -Enters the Bio / chemo informatics arena by setting up Jubilant Biosys Ltd. 2001 -New corporate identity: Jubilant Organosys Ltd. reflecting changed corporate and business profile 2002 -Acquires the Active Pharmaceutical Ingredients business 2003 -Trading symbol of Jubilant Organosys Limited is changed from 'VAMORGANIC ' to 'JUBILANT' -Jubliant Securites Pvt. Ltd. & Jubliant Capital Pvt. Ltd has acquired 4,38,068 (2.99% of total paid up capital) equity shares. -Mr. H K Khan (Retd. IAS) has been appointed as additional director with effect from November 05, 2003 on the Board. 2004 -Jubilant Organosys Limited has informed that the Board of Directors at their meeting held on January 9, 2004 have approved for voluntary delisting of equity shares of the Company from The Delhi Stock Exchange Association Limited, The Calcutta Stock Exchange Association Limited, Kolkata and the Uttar Pradesh Stock Exchange Association Limited subject to the approval of shareholders by special resolution. -Jubilant Organosys acquires generic pharma Companies in Europe -Jubilant Organosys signs international contracts worth US$ 60 million in CRAMS for the year 2007 2005 -Acquired pharmaceutical company in USA involved in off patent drug development and supply, and owns US FDA approved manufacturing facility for solid dosage forms. -Acquires full service Clinical Research Organization in USA involved in providing clinical research services, data management, biostatistics and contract staffing. -Acquires Target Research Associates, Inc., renamed Clinsys Inc.; a US based Clinical Research Organisation (CRO) -Acquires Trinity Laboratories, Inc. and its wholly owned subsidiary, Trigen Laboratories, Inc., renamed Jubilant Pharmaceuticals, Inc., a generic pharmaceutical company in USA having a US FDA approved formulations manufacturing facility -Enters Clinsys Clinical Research Ltd. business by setting up wholly owned subsidiary Jubilant Clinsys Ltd. 2006 -Selected as one of the top 25 companies for Institute of Company Secretaries of India National Award for Excellence in Corporate Governance -Finalist in Golden Peacock Award for Excellence in Corporate Governance -Company has splits its Face value of Shares from Rs 5 to Re 1 2007 -Jubilant Organosys Ltd has acquired 100% equity stake in Hollister-Stier Laboratories LLC, USA, engaged in high growth Injectable contract manufacturing and well established and stable Allergy Immunotherapy businesses. -Acquires Hollister Stier Laboratories in USA, a contract manufacturer of Sterile injectable vials and allergenic extracts. 2008 -Acquires DRAXIS Specialty Pharmaceuticals, Inc. Canada, a contract manufacturer of sterile & non-sterile products and radiopharmaceuticals -Acquires Speciality Molecules Pvt. Ltd. Engaged in the manufacturing of Fine Chemicals used by Life Science Industry including pharma, agro & cosmetic industry. -Jubilant Organosys and Lilly form Drug development joint venture - Uttar Pradesh-based pharma major Jubilant Organosys Ltd (JOL) has secured new contracts worth $92 million (Rs.3.7 billion). The contracts have been signed under Customs Research and Manufacturing Services (CRAMS). Besides marketing its products in the regulated markets of the US, Europe and Japan, the company has managed to make forays into China, said a statement of JOL. 2009 -Jubilant enters into multiple Drug discovery partnerships with leading pharma and biotech -companies such as AstraZeneca, Orion, Endo pharmaceuticals & BioLeap and also extends its collaboration with Lilly for five years. -Jubilant enters into drug development collaborations with academia, University of Alabama at Birmingham and Southern Research Institute (USA) and Duke University (Singapore). -Jubilant Kalpataru - 120 bed super specialty hospital at Barasat, Kolkata, India inaugurated by Hon'ble Minister of Finance Shri Pranab Mukherjee 2010 -ET - IMEA 2009 Platinum Award by Frost & Sullivan, in the Pharmaceutical category for the API facility at Nanjangud -Best CFO (FMCG, Health and Retail Sector) to Mr. R. Sankaraiah by Institute of Chartered Accountants of India in January, 2010 - Jubilant Organosys Ltd has appointed Mr. Shardul S. Shroff as Additional Director of the Company with effect from March 15, 2010. - Jubilant Organosys Ltd has signed a USD 51 million CRAMS contract with a leading Life Sciences Company 2010 -The Company has changed from "Jubilant Organosys Ltd" to "JUBILANT LIFE SCIENCES LTD" -Mr. Shardul S. Shroff has been appointed as Additional Director of the Company. 2011 -Jubilant Life Sciences Ltd has announced another successful delivery of an early stage milestone in the Pain therapeutic area. -Jubilant Org - Jubilant sets up global scale capacities for Symtet - developed through 2012 -JubilantLife - announced today that they have achieved an early stage milestone in one of their collaborative programs with Chadds Ford. -"Jubilant HollisterStier Announces Multi-Million Dollar Award for the manufacture of Sterile Parenteral Products". -"Jubilant SEZ at Bharuch, inaugurated by Shri Narendra Modi, Hon'ble Chief Minister of Gujarat". 2013 - "Jubilant Life Sciences receives prestigious NDTV Profit Business Leadership Award 2012 for Corporate Social Responsibility." - Jubilant Life Sciences receives ANDA approval for Quetiapine Fumarate Tablet -Jubilant Life Sciences declared winner of Supply Chain Excellence Awards' at 7th Express, Logistics & Supply Chain Leadership Awards 2013 2014 - Jubilant Life Scienc - Results of Tender Offer for acquisition of minority shares of Cadista Holdings Inc. - Board recommended a Dividend of Rs.3 per equity shares of Rs.1 -Jubilant Life Sciences wins Excellence Awards at `India Pharma Awards' 2014 -Jubilant Life Sciences conferred with Golden Peacock Business Excellence Award-2014 2015 -Gold Award in Ankleshwar Chapter Convention on Quality Concepts 2015 (ACCQC) -Two Honors at the 10th Annual CIO100 Awards by CIO Magazine - CIO100 Innovation Architect Special Awards 2015 and Versatile 100honorees -Golden Peacock National Quality Award for Quality -Dataquest Business Technology Awards for Best IT Implementation in Analytics, Mobility, Cloud, ERP/CSM/CRM -ASSOCHAM's `Responsible Organization Excellence' Award 2014-15 -50 Most Talented Sustainability Leaders Award -15th Annual Greentech Environment Award 2014 - Gold Category winner under Chemicals and Pharmaceutical sector" - Gajraula plant, India -I.C.O.N.I.C IDC Insights Award, under `Health and Life Sciences vertical 2016 - Jubilant Life Sciences Limited won the Sustainability Award for Best Green Process in Chemical sector of FICCI Chemicals & Petrochemicals Awards, 2016.

Registered Office

Bhartiagram, Gajraula

5924-252351,252356,252358,      5924-252352,



Registrar Details

Alankit Assignment Ltd.